Sign inJoin waitlistJoin the waitlist

Mina Lobbous

Associate Program Director · Cleveland Clinic Foundation

Credentials: · · · ·

History

Cleveland Clinic Foundation
Present

University of Alabama at Birmingham
2019–2021
University of Alabama at Birmingham
2018–2019
Neurology
University of Alabama Hospital
2014–2018
Internal Medicine
University of Alabama at Birmingham
2015–2018
University of Alabama at Birmingham
2014–2015
Ain Shams University Hospital
2011–2012
University of Alabama at Birmingham
Faculty of Medicine, Ain Shams University
2006–2010

Research

An Update on Neurofibromatosis Type 1-Associated Gliomas
Review · Cancers · 2020 · First of 11 authors · Corresponding · 69 citations
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study
Cancer · 2023 · 22 citations
Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US
JAMA Neurology · 2025 · 19 citations

Louis Nabors
9 papers
Andrew Dhawan
4 papers · 2 as a fellow
David Peereboom
4 papers
Galal Elsayed
4 papers · 4 as a resident
Gregory Friedman
4 papers
Gustavo Chagoya
4 papers · 4 as a resident
James Markert
4 papers
John Fiveash
4 papers
JB
Joshua Bernstock
4 papers · 4 as a resident
Matthew Grabowski
4 papers
AT
Alejandro Torres-Trejo
3 papers
Elizabeth Coffee
3 papers · 2 as a resident

Clinical trials

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Site PI · Not yet recruiting · Phase 2
Nuvation Bio Inc.
2027–2032
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Site PI · Recruiting · Phase 3
Nuvation Bio Inc.
2023–2030
Sacituzumab Govitecan in Recurrent Glioblastoma
Site PI · Recruiting · Phase 2
The University of Texas Health Science Center at San Antonio
2022–2028
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Site PI · Recruiting · Phase 2, Phase 3
Global Coalition for Adaptive Research
2019–2030